Cortagen 20mg | 20-Vial Kit | AEDP Brain Bioregulator | Neuroprotection & CNS Research
$450
Cortagen 20mg | 20-Vial Kit — AEDP Khavinson tetrapeptide bioregulator — neural tissue bioregulator studied for neuronal gene expression, cortical neuron differentiation, and neuroprotective pathway research. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Crystagen 20mg | 10-Vial Kit | Pro-Glu-Asp Immune Bioregulator | T-Cell & B-Cell Research
$250
Crystagen (Pro-Glu-Asp / PED tripeptide, Khavinson Cytogen AC-5/AC-6 immune bioregulator) 20mg — >=99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Crystagen 20mg | 20-Vial Kit | Pro-Glu-Asp Immune Bioregulator | T-Cell & B-Cell Research
$450
Crystagen (Pro-Glu-Asp / PED tripeptide, Khavinson Cytogen AC-5/AC-6 immune bioregulator) 20mg — >=99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Dermorphin 10mg | 10-Vial Kit | Opioid Heptapeptide | High-Dose µ-Receptor Research
$270
Dermorphin 10mg | 10-Vial Kit — D-amino acid opioid heptapeptide — 500× higher μ-opioid receptor (MOR) affinity vs. morphine, studied for MOR pharmacology, receptor selectivity, and opioid peptide structure-activity research. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Dermorphin 10mg | 20-Vial Kit | Opioid Heptapeptide | High-Dose µ-Receptor Research
$490
Dermorphin 10mg | 20-Vial Kit — D-amino acid opioid heptapeptide — 500× higher μ-opioid receptor (MOR) affinity vs. morphine, studied for MOR pharmacology, receptor selectivity, and opioid peptide structure-activity research. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Dermorphin 5mg | 10-Vial Kit | Opioid Heptapeptide | µ-Receptor Research
$240
Dermorphin 5mg | 10-Vial Kit — D-amino acid opioid heptapeptide — 500× higher μ-opioid receptor (MOR) affinity vs. morphine, studied for MOR pharmacology, receptor selectivity, and opioid peptide structure-activity research. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Dermorphin 5mg | 20-Vial Kit | Opioid Heptapeptide | µ-Receptor Research
$430
Dermorphin 5mg | 20-Vial Kit — D-amino acid opioid heptapeptide — 500× higher μ-opioid receptor (MOR) affinity vs. morphine, studied for MOR pharmacology, receptor selectivity, and opioid peptide structure-activity research. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Dihexa 10mg | 10-Vial Kit | HGF/MET Nootropic Peptide | High-Dose Cognitive Research
$280
Dihexa 10mg | 10-Vial Kit — HGF/MET agonist heptapeptide (PNB-0408) — activates hepatocyte growth factor receptor to drive hippocampal synaptogenesis and dendritic spine density; studied for cognitive enhancement and memory improvement. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Dihexa 10mg | 20-Vial Kit | HGF/MET Nootropic Peptide | High-Dose Cognitive Research
$510
Dihexa 10mg | 20-Vial Kit — HGF/MET agonist heptapeptide (PNB-0408) — activates hepatocyte growth factor receptor to drive hippocampal synaptogenesis and dendritic spine density; studied for cognitive enhancement and memory improvement. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Dihexa 5mg | 10-Vial Kit | HGF/MET Nootropic Peptide | Cognitive & Synaptogenic Research
$220
Dihexa 5mg | 10-Vial Kit — HGF/MET agonist heptapeptide (PNB-0408) — activates hepatocyte growth factor receptor to drive hippocampal synaptogenesis and dendritic spine density; studied for cognitive enhancement and memory improvement. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Dihexa 5mg | 20-Vial Kit | HGF/MET Nootropic Peptide | Cognitive & Synaptogenic Research
$390
Dihexa 5mg | 20-Vial Kit — HGF/MET agonist heptapeptide (PNB-0408) — activates hepatocyte growth factor receptor to drive hippocampal synaptogenesis and dendritic spine density; studied for cognitive enhancement and memory improvement. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
DSIP 10mg | 10-Vial Kit | Sleep Peptide Kit
$220
DSIP 10mg | 10-Vial Kit — Delta sleep-inducing nonapeptide — studied for slow-wave sleep architecture modulation, HPA axis normalisation, and circadian rhythm regulation independent of sedative receptor pathways. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
DSIP 10mg | 20-Vial Kit | Sleep Peptide Kit
$390
DSIP 10mg | 20-Vial Kit — Delta sleep-inducing nonapeptide — studied for slow-wave sleep architecture modulation, HPA axis normalisation, and circadian rhythm regulation independent of sedative receptor pathways. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
DSIP 15mg | 10-Vial Kit | Sleep Peptide Kit
$260
DSIP 15mg | 10-Vial Kit — Delta sleep-inducing nonapeptide — studied for slow-wave sleep architecture modulation, HPA axis normalisation, and circadian rhythm regulation independent of sedative receptor pathways. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
DSIP 15mg | 20-Vial Kit | Sleep Peptide Kit
$470
DSIP 15mg | 20-Vial Kit — Delta sleep-inducing nonapeptide — studied for slow-wave sleep architecture modulation, HPA axis normalisation, and circadian rhythm regulation independent of sedative receptor pathways. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Out of stock
DSIP 2mg | 10-Vial Kit | Delta Sleep-Inducing Peptide | Sleep & Neuroendocrine Research
$190
DSIP 2mg | 10-Vial Kit — Delta sleep-inducing nonapeptide — studied for slow-wave sleep architecture modulation, HPA axis normalisation, and circadian rhythm regulation independent of sedative receptor pathways. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Notify Me
Out of stock
DSIP 2mg | 20-Vial Kit | Delta Sleep-Inducing Peptide | Sleep & Neuroendocrine Research
$330
DSIP 2mg | 20-Vial Kit — Delta sleep-inducing nonapeptide — studied for slow-wave sleep architecture modulation, HPA axis normalisation, and circadian rhythm regulation independent of sedative receptor pathways. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Notify Me
DSIP 5mg | 10-Vial Kit | Sleep Peptide Kit
$210
DSIP 5mg | 10-Vial Kit — Delta sleep-inducing nonapeptide — studied for slow-wave sleep architecture modulation, HPA axis normalisation, and circadian rhythm regulation independent of sedative receptor pathways. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
DSIP 5mg | 20-Vial Kit | Sleep Peptide Kit
$370
DSIP 5mg | 20-Vial Kit — Delta sleep-inducing nonapeptide — studied for slow-wave sleep architecture modulation, HPA axis normalisation, and circadian rhythm regulation independent of sedative receptor pathways. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Dulaglutide 10mg | 10-Vial Kit | Long-Acting GLP-1R Agonist | High-Dose Metabolic Research
$460
Dulaglutide 10mg | 10-Vial Kit — Long-acting GLP-1 receptor agonist (LY2189265) — GLP-1 analogue fused to IgG4 Fc fragment for extended 7–14 day half-life, enabling once-weekly administration in research models. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Dulaglutide 10mg | 20-Vial Kit | Long-Acting GLP-1R Agonist | High-Dose Metabolic Research
$870
Dulaglutide 10mg | 20-Vial Kit — Long-acting GLP-1 receptor agonist (LY2189265) — GLP-1 analogue fused to IgG4 Fc fragment for extended 7–14 day half-life, enabling once-weekly administration in research models. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Dulaglutide 5mg | 10-Vial Kit | GLP-1R Agonist Fc-Fusion | Metabolic Research
$350
Dulaglutide 5mg | 10-Vial Kit — Long-acting GLP-1 receptor agonist (LY2189265) — GLP-1 analogue fused to IgG4 Fc fragment for extended 7–14 day half-life, enabling once-weekly administration in research models. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Dulaglutide 5mg | 20-Vial Kit | GLP-1R Agonist Fc-Fusion | Metabolic Research
$650
Dulaglutide 5mg | 20-Vial Kit — Long-acting GLP-1 receptor agonist (LY2189265) — GLP-1 analogue fused to IgG4 Fc fragment for extended 7–14 day half-life, enabling once-weekly administration in research models. ≥99% HPLC purity, MS confirmed, Janoshik COA. Research use only.
Out of stock
Eloralintide 1mg | MEDI0382 | Dual GLP-1R/GCGR Agonist | Research Grade
$300
Eloralintide (MEDI0382 / Cotadutide) — Dual GLP-1R/GCGR co-agonist — ≥99% HPLC purity, MS confirmed, Janoshik COA. Phase 2: ~10–11% weight loss, ~40–50% liver fat reduction. Research use only.
Notify Me